Exsurco Medical, Inc.

Exsurco Medical, Inc. manufactures pneumatically powered surgical devices for skin grafting, wound debridement, and tissue processing. The company serves two primary markets: operating room surgical teams and tissue bank professionals. The flagship Amalgatome® SD is a multi-purpose surgical device for acute and chronic wound debridement and split-thickness skin graft harvesting in burn and trauma patients, with adjustable cutting depth (0.005" to 0.045") and dual cutting head sizes (2" and 4"). The Amalgatome® MD and Amalgatome® SK are specialized tissue processing devices designed for cadaveric allograft recovery in tissue banks, engineered to improve yield, maneuverability over body contours, and efficiency in skin and adipose tissue removal. Clinical evidence supports the Amalgatome SD for improved graft uniformity, faster operative time, reduced anesthesia exposure, and enhanced donor tissue yield. The technology is referenced in peer-reviewed literature, including a consensus paper published in Eplasty Journal. The company provides training videos and educational materials for surgical and tissue bank professionals. Regulatory status and specific certifications (FDA clearance, ISO compliance) are not explicitly stated on the fetched website content.